vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Patient Education

  • Educate patient, friends & relatives about the disease
    • It is important for them to overcome any stigmas they may have about vitiligo
  • Explain the nature of the disease to the patient
    • Vitiligo does not effect the patient’s health directly, but is a cosmetic issue
    • Spontaneous recovery may occur
  • Treatment options should be discussed
    • Treatment may be long & difficult, & the results are often unpredictable
    • Review the risks vs benefits along w/ expected outcomes of the treatment options
Editor's Recommendations
Most Read Articles
25 Apr 2019
A recent study has demonstrated the potential of clindamycin as a treatment alternative to antibiotic combination regardless of hidradenitis suppurativa (HS) clinical stage.
01 May 2019
New drug applications approved by US FDA as of 16 - 30 April 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.